Trial intelligence / Profile preview

Quick-Acting Heart Reliever for Moderate Coronary Stenosis

NCT01513070Phase 4Completed

Sponsor
Guang'anmen Hospital
Start
Apr 2012
Primary completion
Jul 2012
Modality
Implantable Devices, Transdermal Patches, Inhalation Devices
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of Suxiao Jiuxin Pills in angina pectoris and coronary stenosis (2 arms), sponsored by Guang'anmen Hospital. Primary endpoint: Effective power of angina pectoris at 6 months. Started Apr 2012; status: completed.

02

Drugs

Suxiao Jiuxin Pills
03

Conditions

angina pectoriscoronary stenosis

Beyond the preview

Go deeper on NCT01513070.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01513070.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call